DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York
16 Junho 2022 - 2:30AM
DBV Technologies to Present at the JMP Securities Life Sciences
Conference in New York
Montrouge, France, June 16, 2022
DBV Technologies to
Present at the JMP Securities
Life Sciences Conference in New
York
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced that Daniel Tassé, Chief
Executive Officer, and Dr. Pharis Mohideen, Chief Medical Officer,
will participate in a fireside chat on Thursday, June 16, 2022, at
12:00 p.m. ET at the JMP Securities Life Sciences Conference in New
York.
A webcast of the presentation will be available
on the Investors & Media section of the Company’s website:
https://www.dbv-technologies.com/investor-relations/
A replay of the presentation will also be
available on DBV Technologies’ website after the event.
About DBV TechnologiesDBV
Technologies is developing Viaskin™, an investigational proprietary
technology platform with broad potential applications in
immunotherapy. Viaskin is based on epicutaneous immunotherapy, or
EPIT™, DBV’s method of delivering biologically active compounds to
the immune system through intact skin. With this new class of
non-invasive product candidates, the Company is dedicated to safely
transforming the care of food allergic patients. DBV Technologies’
food allergies programs include ongoing clinical trials of Viaskin
Peanut. DBV Technologies has global headquarters in Montrouge,
France, and North American operations in Basking Ridge, NJ. The
Company’s ordinary shares are traded on segment B of Euronext Paris
(Ticker: DBV, ISIN code: FR0010417345), and the Company’s ADSs
(each representing one-half of one ordinary share) are traded on
the Nasdaq Global Select Market (Ticker: DBVT).
Investor
Contact Anne PollakDBV Technologies+1
857-529-2363anne.pollak@dbv-technologies.com
Media
ContactAngela MarcucciDBV
Technologies+1 646-842-2393angela.marcucci@dbv-technologies.com
DBV Technologies (EU:DBV)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
DBV Technologies (EU:DBV)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024